EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statistical Genetics of DMD Gene Mutations in a Kazakhstan Cohort: MLPA/NGS Variant Validation and Genotype–Phenotype Modelling

Aizhan Moldakaryzova iD, Dias Dautov, Saken Khaidarov iD, Saniya Ossikbayeva iD, Dilyara Kaidarova iD

Genes · 2025

DOI: 10.3390/genes17010020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Aizhan Moldakaryzova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Medical Genetics, Asfendiyarov Kazakh National Medical University, Zheltoksan 37A Street, Almaty 050012, Kazakhst…. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Mutation, Dystrophin. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan, Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Duchenne muscular dystrophy (DMD) results from pathogenic variants in the DMD gene, one of the most significant and most mutation-prone genes in the human genome. Although global mutation registries are well developed, genetic data from Central Asian populations remain extremely limited, leaving essential gaps in regional epidemiology and in the understanding of genotype–phenotype patterns.

Methods

We conducted a retrospective analysis of patients with genetically confirmed dystrophinopathy in Kazakhstan. Variants were identified using multiplex ligation-dependent probe amplification (MLPA) for exon-level copy number alterations and next-generation sequencing (NGS) with Sanger confirmation for sequence-level changes. All variants were classified under ACMG guidelines. Statistical modelling incorporated mutation-class grouping, exon-hotspot mapping, reading-frame status, CPK stratification, chi-squared association testing, Spearman correlations, Kaplan–Meier ambulation survival curves, and multivariable logistic and Cox regression. Results: multi-exon deletions were the predominant mutation class, with a marked concentration within the canonical hotspot spanning exons 44–55. Recurrent deletions affecting exons 46–50 and 45–50 appeared in several unrelated patients. NGS confirmed severe protein-truncating variants, including p. Lys1049* and p. Ser861Ilefs*7. Phenotypic severity followed a consistent hierarchy: hotspot-associated deletions and early truncating variants showed the earliest loss of ambulation, whereas splice-site variants and duplications demonstrated the mildest courses. CPK levels correlated with the extent of genomic involvement, though extreme elevations did not consistently predict early functional decline. Regression models identified hotspot localization and out-of-frame effect as independent predictors of ambulation loss.

Conclusions

This study provides the first statistically modelled characterisation of DMD gene mutations in Kazakhstan. While the mutational landscape largely mirrors global patterns, notable variability in clinical severity suggests the presence of population-specific modifiers. Integrating comprehensive molecular diagnostics with statistical-genetics approaches enhances prognostic accuracy and supports the development of mutation-targeted therapeutic strategies in Central Asia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneMutationDystrophinHumansGenetic Association StudiesKazakhstanHigh-Throughput Nucleotide SequencingMalePhenotypeChildExonsChild, PreschoolRetrospective StudiesMultiplex Polymerase Chain Reaction

Stichwörter der Autor:innen

ACMG classificationCentral AsiaDMD geneDuchenne muscular dystrophyMLPANGSdeletion hotspotgenotype–phenotype correlationstatistical geneticssurvival analysis

Substanzen

DystrophinDMD protein, human

Autor:innen und Institutionen

  • Department of Molecular Biology and Medical Genetics, Asfendiyarov Kazakh National Medical University, Zheltoksan 37A Street, Almaty 050012, Kazakhstan.
  • Centre for Orphan Diseases with Neurological Manifestations in Children at the Republican Children's Clinical Hospital "Aksai" of KazNMU Named After S.D. Asfendiyarov, Tautagan 2a, Almaty 050000, Kazakhstan.
  • Department of Molecular Genetic Research Center JS, Kazakh Institute of Oncology and Radiology, Almaty 050022, Kazakhstan.
  • First Vice-Rector, Asfendiyarov Kazakh National Medical University, Tole-Bi Street 94, Almaty 050012, Kazakhstan.

ORCID-Profile: Aizhan Moldakaryzova, Saken Khaidarov, Saniya Ossikbayeva, Dilyara Kaidarova

Förderung

  • the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
  • Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Moldakaryzova, A., Dautov, D., Khaidarov, S., Ossikbayeva, S., & Kaidarova, D. (2025). Statistical Genetics of DMD Gene Mutations in a Kazakhstan Cohort: MLPA/NGS Variant Validation and Genotype–Phenotype Modelling. Genes. https://doi.org/10.3390/genes17010020

Vancouver

Moldakaryzova A, Dautov D, Khaidarov S, Ossikbayeva S, Kaidarova D. Statistical Genetics of DMD Gene Mutations in a Kazakhstan Cohort: MLPA/NGS Variant Validation and Genotype–Phenotype Modelling. Genes. 2025. doi:10.3390/genes17010020

BibTeX
@article{Moldakaryzova2025,
  author = {Moldakaryzova, Aizhan and Dautov, Dias and Khaidarov, Saken and Ossikbayeva, Saniya and Kaidarova, Dilyara},
  title = {Statistical Genetics of DMD Gene Mutations in a Kazakhstan Cohort: MLPA/NGS Variant Validation and Genotype–Phenotype Modelling},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes17010020}
}
Kostenlos starten →